Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.15M | -4.63M | -4.70M | -6.56M | -7.58M |
| Total Depreciation and Amortization | 138.00K | 142.00K | 144.00K | 156.00K | 157.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 717.00K | 1.94M | 1.36M | 1.37M | 1.39M |
| Change in Net Operating Assets | 2.59M | -394.00K | -1.24M | 700.00K | -315.00K |
| Cash from Operations | -702.00K | -2.94M | -4.44M | -4.33M | -6.34M |
| Capital Expenditure | -55.00K | -245.00K | -153.00K | -289.00K | -35.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -55.00K | -245.00K | -153.00K | -289.00K | -35.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -5.00K | -5.00K | -5.00K | -5.00K |
| Issuance of Common Stock | -- | 7.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.00K | -235.00K | -- | -- | -- |
| Cash from Financing | 25.00K | 6.76M | -5.00K | -5.00K | -5.00K |
| Foreign Exchange rate Adjustments | 2.00K | 150.00K | -67.00K | 19.00K | 11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -730.00K | 3.73M | -4.67M | -4.60M | -6.37M |